Spatial transcriptomics and scRNA-seq demonstrated the robust expression of estrogen receptor 1 (ESR1) and progesterone receptor (PGR) in fibroids with significant involvement of the ERK1/ERK2 pathway in mediating hormonal effects and promoting tumor progression. Here, MAPK3 is linked to neoplasm.